The global ophthalmic suspension market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of eye disorders and the rising demand for ophthalmic drugs.
Antibiotic, antifungal, antibacterial, steroids and NSAIDs are some of the types in this market. Antibiotics are used for bacterial infections; antifungals are used for fungal infections; antibacterials are used for bacterial infections; steroids are used in glaucoma treatment and allergies treatment; NSAIDs are used in diabetic eye disease treatment. The application segment includes bacterial infection, retinal disorders, glaucoma, allergies and diabetic eye disease. North America is expected to dominate this market with a share of about 40%.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of eye diseases.
- Increasing awareness about eye care.
- Growing geriatric population.
- Rising disposable income.
- Technological advancements in ophthalmic surgery.
Industry Growth Insights published a new data on “Ophthalmic Suspension Market”. The research report is titled “Ophthalmic Suspension Market research by Types (Antibiotic, Antifungal, Antibacterial, Steroids, NSAIDs), By Applications (Bacterial Infections, Retinal Disorders, Glaucoma, Allergies, Diabetic Eye Disease), By Players/Companies Allergan, Merck, Novartis, Bausch & Lomb, Falcon Group, Pfizer, Valeant, ...”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ophthalmic Suspension Market Research Report
By Type
Antibiotic, Antifungal, Antibacterial, Steroids, NSAIDs
By Application
Bacterial Infections, Retinal Disorders, Glaucoma, Allergies, Diabetic Eye Disease
By Companies
Allergan, Merck, Novartis, Bausch & Lomb, Falcon Group, Pfizer, Valeant, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Ophthalmic Suspension Market Report Segments:
The global Ophthalmic Suspension market is segmented on the basis of:
Types
Antibiotic, Antifungal, Antibacterial, Steroids, NSAIDs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bacterial Infections, Retinal Disorders, Glaucoma, Allergies, Diabetic Eye Disease
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Merck
- Novartis
- Bausch & Lomb
- Falcon Group
- Pfizer
- Valeant
- ...
Highlights of The Ophthalmic Suspension Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotic
- Antifungal
- Antibacterial
- Steroids
- NSAIDs
- By Application:
- Bacterial Infections
- Retinal Disorders
- Glaucoma
- Allergies
- Diabetic Eye Disease
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ophthalmic Suspension Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ophthalmic suspension is a medication that is used to lower the pressure in the eye. It is usually given as an injection into one of the eyes.
Some of the key players operating in the ophthalmic suspension market are Allergan, Merck, Novartis, Bausch & Lomb, Falcon Group, Pfizer, Valeant.
The ophthalmic suspension market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ophthalmic Suspension Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ophthalmic Suspension Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ophthalmic Suspension Market - Supply Chain
4.5. Global Ophthalmic Suspension Market Forecast
4.5.1. Ophthalmic Suspension Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ophthalmic Suspension Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ophthalmic Suspension Market Absolute $ Opportunity
5. Global Ophthalmic Suspension Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ophthalmic Suspension Market Size and Volume Forecast by Type
5.3.1. Antibiotic
5.3.2. Antifungal
5.3.3. Antibacterial
5.3.4. Steroids
5.3.5. NSAIDs
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ophthalmic Suspension Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ophthalmic Suspension Market Size and Volume Forecast by Application
6.3.1. Bacterial Infections
6.3.2. Retinal Disorders
6.3.3. Glaucoma
6.3.4. Allergies
6.3.5. Diabetic Eye Disease
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ophthalmic Suspension Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ophthalmic Suspension Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ophthalmic Suspension Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ophthalmic Suspension Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ophthalmic Suspension Demand Share Forecast, 2019-2029
9. North America Ophthalmic Suspension Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ophthalmic Suspension Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ophthalmic Suspension Market Size and Volume Forecast by Application
9.4.1. Bacterial Infections
9.4.2. Retinal Disorders
9.4.3. Glaucoma
9.4.4. Allergies
9.4.5. Diabetic Eye Disease
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ophthalmic Suspension Market Size and Volume Forecast by Type
9.7.1. Antibiotic
9.7.2. Antifungal
9.7.3. Antibacterial
9.7.4. Steroids
9.7.5. NSAIDs
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ophthalmic Suspension Demand Share Forecast, 2019-2029
10. Latin America Ophthalmic Suspension Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ophthalmic Suspension Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ophthalmic Suspension Market Size and Volume Forecast by Application
10.4.1. Bacterial Infections
10.4.2. Retinal Disorders
10.4.3. Glaucoma
10.4.4. Allergies
10.4.5. Diabetic Eye Disease
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ophthalmic Suspension Market Size and Volume Forecast by Type
10.7.1. Antibiotic
10.7.2. Antifungal
10.7.3. Antibacterial
10.7.4. Steroids
10.7.5. NSAIDs
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ophthalmic Suspension Demand Share Forecast, 2019-2029
11. Europe Ophthalmic Suspension Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ophthalmic Suspension Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ophthalmic Suspension Market Size and Volume Forecast by Application
11.4.1. Bacterial Infections
11.4.2. Retinal Disorders
11.4.3. Glaucoma
11.4.4. Allergies
11.4.5. Diabetic Eye Disease
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ophthalmic Suspension Market Size and Volume Forecast by Type
11.7.1. Antibiotic
11.7.2. Antifungal
11.7.3. Antibacterial
11.7.4. Steroids
11.7.5. NSAIDs
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ophthalmic Suspension Demand Share, 2019-2029
12. Asia Pacific Ophthalmic Suspension Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ophthalmic Suspension Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ophthalmic Suspension Market Size and Volume Forecast by Application
12.4.1. Bacterial Infections
12.4.2. Retinal Disorders
12.4.3. Glaucoma
12.4.4. Allergies
12.4.5. Diabetic Eye Disease
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ophthalmic Suspension Market Size and Volume Forecast by Type
12.7.1. Antibiotic
12.7.2. Antifungal
12.7.3. Antibacterial
12.7.4. Steroids
12.7.5. NSAIDs
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ophthalmic Suspension Demand Share, 2019-2029
13. Middle East & Africa Ophthalmic Suspension Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ophthalmic Suspension Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ophthalmic Suspension Market Size and Volume Forecast by Application
13.4.1. Bacterial Infections
13.4.2. Retinal Disorders
13.4.3. Glaucoma
13.4.4. Allergies
13.4.5. Diabetic Eye Disease
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ophthalmic Suspension Market Size and Volume Forecast by Type
13.7.1. Antibiotic
13.7.2. Antifungal
13.7.3. Antibacterial
13.7.4. Steroids
13.7.5. NSAIDs
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ophthalmic Suspension Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Ophthalmic Suspension Market: Market Share Analysis
14.2. Ophthalmic Suspension Distributors and Customers
14.3. Ophthalmic Suspension Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allergan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novartis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bausch & Lomb
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Falcon Group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pfizer
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Valeant
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ...
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
